Table 1 Characteristics of study population according to significant vascular calcification
Characteristics | Significant vascular calcification | ||
|---|---|---|---|
Positive (n = 41) | Negative (n = 26) | P-value | |
Age (years) | 59.6 ± 9.2 | 51.12 ± 10.0 | 0.001 |
Male, n (%) | 13(38.2%) | 9(40.9%) | 1.000 |
Diabetes, n (%) | 26(75.8%) | 8(24.2%) | 0.015 |
HD/PD, n | 26/15 | 15/11 | 0.415 |
CIMT, Right. (mm) | 0.97 ± 0.19 | 0.77 ± 0.21 | 0.006 |
CIMT, Left (mm) | 0.97 ± 0.21 | 0.74 ± 0.13 | 0.001 |
Carotid atheroma (%) | 73.9 | 23.1 | 0.003 |
MIS | 4.6 ± 2.7 | 3.3 ± 52.7 | 0.007 |
Dialysis duration (months) | 44.6 ± 32.9 | 36.1 ± 37.1 | 0.333 |
Body mass index (kg/m2) | 23.6 ± 3.0 | 23.1 ± 3.1 | 0.674 |
Hemoglobin (g/dL) | 10.4 ± 1.0 | 10.5 ± 1.2 | 0.867 |
PTH (pg/mL) | 295.5 ± 264.8 | 411.9 ± 343.3 | 0.158 |
Calcium (mg/dL) | 8.8 ± 0.7 | 8.7 ± 0.7 | 0.811 |
Phosphorous (mg/dL) | 4.7 ± 1.5 | 4.8 ± 1.5 | 0.719 |
Creatinine (mg/dL) | 12.5 ± 16.2 | 10.3 ± 2.8 | 0.857 |
Albumin (g/dL) | 3.9 ± 0.3 | 4.0 ± 0.3 | 0.035 |
TIBC (ug/dl) | 245.0 ± 46.7 | 288.6 ± 33.7 | 0.017 |
CRP (mg/dL) | 0.9 ± 1.5 | 0.2 ± 0.4 | 0.000 |